{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:12Z","timestamp":1792686252196,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":240,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009988","name":"Huzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100991","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:39:56Z","timestamp":1757086796000},"page":"100991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Upregulation of FLT1 activates the TGF-\u03b21\/Smad3 pathway to promote iodide resistance in thyroid cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"Jing","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctarc.2025.100991_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8759","article-title":"Global burden of thyroid cancer from 1990 to 2017","volume":"3","author":"Deng","year":"2020","journal-title":"JAMa Netw. Open."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100991_bib0002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","article-title":"Thyroid cancer: incidence and mortality trends in China, 2005-2015","volume":"68","author":"Wang","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100991_bib0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/EJE-17-0260","article-title":"Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis","volume":"177","author":"Vuong","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100991_bib0004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid Cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMa"},{"issue":"5","key":"10.1016\/j.ctarc.2025.100991_bib0005","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0146","article-title":"Management of follicular thyroid carcinoma","volume":"13","author":"Yamazaki","year":"2024","journal-title":"Eur. Thyroid. J."},{"issue":"20","key":"10.1016\/j.ctarc.2025.100991_bib0006","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-16-0484","article-title":"Thyroid cancer: risk-stratified management and individualized therapy","volume":"22","author":"Raue","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2025.100991_bib0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-physiol-022516-034125","article-title":"The sodium\/iodide symporter (NIS): molecular physiology and preclinical and clinical applications","volume":"79","author":"Ravera","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"10","key":"10.1016\/j.ctarc.2025.100991_bib0008","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1210\/jc.2018-00612","article-title":"Targeted therapy in advanced thyroid cancer to resensitize tumors to radioactive iodine","volume":"103","author":"Jaber","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100991_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ctarc.2025.100991_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mce.2017.01.038","article-title":"Thyroid hormone biosynthesis and release","volume":"458","author":"Carvalho","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100991_bib0011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2012.06.007","article-title":"The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics","volume":"135","author":"Kogai","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.ctarc.2025.100991_bib0012","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100991_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.23736\/S0026-4806.17.04923-0","article-title":"Effect of excess iodine intake on thyroid on human health","volume":"108","author":"Koukkou","year":"2017","journal-title":"Minerva Med."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100991_bib0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12011-017-1017-z","article-title":"Iodinated TG in thyroid follicles regulate TSH\/TSHR signaling for NIS expression","volume":"180","author":"Huang","year":"2017","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100991_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/ERC-18-0173","article-title":"TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer","volume":"26","author":"Schug","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ctarc.2025.100991_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6840642","article-title":"Downregulation of Rap1GAP expression activates the TGF-\u03b2\/Smad3 pathway to inhibit the expression of sodium\/iodine transporter in papillary thyroid carcinoma cells","volume":"2021","author":"Yan","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.ctarc.2025.100991_bib0017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00535-017-1350-1","article-title":"TGF-\u03b2 in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota","volume":"52","author":"Ihara","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100991_bib0018","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13287-021-02349-y","article-title":"DPSCs treated by TGF-\u03b21 regulate angiogenic sprouting of three-dimensionally co-cultured HUVECs and DPSCs through VEGF-Ang-Tie2 signaling","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100991_bib0019","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1357-2725(01)00026-7","article-title":"Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)","volume":"33","author":"Shibuya","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ctarc.2025.100991_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phrs.2018.08.023","article-title":"Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors","volume":"136","author":"Lacal","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100991_bib0021","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20141555","article-title":"FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis","volume":"212","author":"Qian","year":"2015","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100991_bib0022","first-page":"2139","article-title":"MicroRNA-139-5p\/Flt1\/wnt\/\u03b2-catenin regulatory crosstalk modulates the progression of glioma","volume":"41","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"7069","key":"10.1016\/j.ctarc.2025.100991_bib0023","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.ctarc.2025.100991_bib0024","doi-asserted-by":"crossref","first-page":"D762","DOI":"10.1093\/nar\/gkx1020","article-title":"The UCSC Genome Browser database: 2018 update","volume":"46","author":"Casper","year":"2018","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.ctarc.2025.100991_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-0512-6_3","article-title":"edgeR for differential RNA-seq and ChIP-seq analysis: an application to stem cell biology","volume":"1150","author":"Nikolayeva","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100991_bib0026","first-page":"283","volume":"38","author":"Kurien","year":"2006","journal-title":"Western blotting. Methods"},{"issue":"18","key":"10.1016\/j.ctarc.2025.100991_bib0027","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2217\/fon-2019-0780","article-title":"Metastatic propagation of thyroid cancer; organ tropism and major modulators","volume":"16","author":"Rajabi","year":"2020","journal-title":"Future Oncol."},{"issue":"15","key":"10.1016\/j.ctarc.2025.100991_bib0028","first-page":"14","article-title":"Strategies for radioiodine treatment: what's new","author":"Sparano","year":"2022","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ctarc.2025.100991_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100939","article-title":"Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy","volume":"68","author":"Liu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.ctarc.2025.100991_bib0030","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1210\/jc.2019-00040","article-title":"IL13RA2 Is differentially regulated in papillary thyroid carcinoma vs follicular thyroid carcinoma","volume":"104","author":"Chong","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100991_bib0031","article-title":"CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100991_bib0032","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ctarc.2025.100991_bib0033","doi-asserted-by":"crossref","first-page":"R465","DOI":"10.1530\/ERC-19-0163","article-title":"Role of chemokine receptors in thyroid cancer and immunotherapy","volume":"26","author":"Coperchini","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2025.100991_bib0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2613.2007.00533.x","article-title":"Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases","volume":"88","author":"Jebreel","year":"2007","journal-title":"Int. J. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100991_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1507\/endocrj.45.35","article-title":"Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions","volume":"45","author":"Shingu","year":"1998","journal-title":"Endocr. J."},{"issue":"7","key":"10.1016\/j.ctarc.2025.100991_bib0036","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9940","key":"10.1016\/j.ctarc.2025.100991_bib0037","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:39:35Z","timestamp":1765485575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"alternative-id":["S2468294225001273"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100991","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of FLT1 activates the TGF-\u03b21\/Smad3 pathway to promote iodide resistance in thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100991"}}